BIOCHEMICAL AND GENOMIC CHARACTERIZATION OF HUMAN LEUKOTRIENE C4 SYNTHASE

人白三烯 C4 合成酶的生物化学和基因组特征

基本信息

  • 批准号:
    6235027
  • 负责人:
  • 金额:
    $ 16.22万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1997
  • 资助国家:
    美国
  • 起止时间:
    1997-09-01 至 1998-08-31
  • 项目状态:
    已结题

项目摘要

Leukotriene (LT) synthase is the terminal enzyme of 5-lipoxygenase pathway that is involved in conjugating the unstable epoxide intermediate, LTA4, with glutathione (GSH) to form LTC4. Hence, LTC4 synthase can regulate the biosynthesis of this potent mediator, which contributes to the pathobiology of bronchial asthma through its metabolites, LTD4 and LTE4. The overall objective of this project is to define tissue/cellular and subcellular distribution of LTC4 synthase, to characterize in biochemical and molecular terms the conjugation of LTA4 with reduced GSH by this novel protein, and to clone the gene so as to study its regulation. The cellular localization of LTC4 synthase in human lung tissue from individuals with and without asthma as well as the subcellular distribution of LTC4 synthase in normal and leukemic cell lines will be studied by immunohistochemistry and by immunogold labeling electron microscopy with polyclonal antibodies raised against purified LTC4 synthase derived from human lung. The kinetic studies will be performed on recombinant enzyme purified from baculovirus-infected insect cells after S-hexyl GSH chromatography and LTC affinity chromatography or if necessary, by antibody affinity chromatography or affinity chromatography of a tagged protein with subsequent removal of the tag. The structural relationship of LTC4 synthase to function will be determined by examining the enzyme kinetics of the mutated protein obtained by site-directed mutagenesis and by the use of substrate analogs. The LTC4 synthase gene will be cloned from a human leukocyte EMBL-3 genomic library using near full length LTC4 synthase cDNA as a probe. Up to 3 kilobases (kb) of the 5 prime flanking region of the gene will be sequenced and its cis-acting element will be examined with a DNase I hypersensitivity assay and by transfection of enhancerless and promoterless human growth hormone expression plasmid (p-phi-GH).
白三烯(LT)合成酶是5-脂氧合酶的末端酶

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

BING K LAM其他文献

BING K LAM的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('BING K LAM', 18)}}的其他基金

Mast Cell Derived PGD2 and LTC4 in Lung Inflammation
肥大细胞衍生的 PGD2 和 LTC4 在肺部炎症中的作用
  • 批准号:
    7422407
  • 财政年份:
    2007
  • 资助金额:
    $ 16.22万
  • 项目类别:
Immune Regulation of Cysteinyl Leukotriene Biosynthesis
半胱氨酰白三烯生物合成的免疫调节
  • 批准号:
    7394967
  • 财政年份:
    2007
  • 资助金额:
    $ 16.22万
  • 项目类别:
Immune Regulation of Cysteinyl Leukotriene Biosynthesis
半胱氨酰白三烯生物合成的免疫调节
  • 批准号:
    7258510
  • 财政年份:
    2007
  • 资助金额:
    $ 16.22万
  • 项目类别:
Immune Regulation of Cysteinyl Leukotriene Biosynthesis
半胱氨酰白三烯生物合成的免疫调节
  • 批准号:
    7571588
  • 财政年份:
    2007
  • 资助金额:
    $ 16.22万
  • 项目类别:
Immune Regulation of Cysteinyl Leukotriene Biosynthesis
半胱氨酰白三烯生物合成的免疫调节
  • 批准号:
    7760131
  • 财政年份:
    2007
  • 资助金额:
    $ 16.22万
  • 项目类别:
Mast Cell Derived PGD2 and LTC4 in Lung Inflammation
肥大细胞衍生的 PGD2 和 LTC4 在肺部炎症中的作用
  • 批准号:
    7312455
  • 财政年份:
    2006
  • 资助金额:
    $ 16.22万
  • 项目类别:
Mast Cell Derived PGD2 and LTC4 in Lung Inflammation
肥大细胞衍生的 PGD2 和 LTC4 在肺部炎症中的作用
  • 批准号:
    7098417
  • 财政年份:
    2005
  • 资助金额:
    $ 16.22万
  • 项目类别:
BIOCHEMICAL AND GENOMIC REGULATION OF HUMAN LTC SYNTHASE
人类 LTC 合成酶的生化和基因组调控
  • 批准号:
    6654612
  • 财政年份:
    2002
  • 资助金额:
    $ 16.22万
  • 项目类别:
BIOCHEMICAL AND GENOMIC REGULATION OF HUMAN LTC SYNTHASE
人类 LTC 合成酶的生化和基因组调控
  • 批准号:
    6496750
  • 财政年份:
    2001
  • 资助金额:
    $ 16.22万
  • 项目类别:
BIOCHEMICAL AND GENOMIC REGULATION OF HUMAN LTC SYNTHASE
人类 LTC 合成酶的生化和基因组调控
  • 批准号:
    6353059
  • 财政年份:
    2000
  • 资助金额:
    $ 16.22万
  • 项目类别:

相似海外基金

Defining new asthma phenotypes using high-dimensional data
使用高维数据定义新的哮喘表型
  • 批准号:
    2901112
  • 财政年份:
    2024
  • 资助金额:
    $ 16.22万
  • 项目类别:
    Studentship
Basophilic oncostatin M fuels nociceptor neuron-induced asthma
嗜碱性制瘤素 M 促进伤害感受器神经元诱发哮喘
  • 批准号:
    485504
  • 财政年份:
    2023
  • 资助金额:
    $ 16.22万
  • 项目类别:
    Salary Programs
Engaging Patient and Caregivers in Using Patient-reported Outcomes Measures in Pediatric Clinical Care for Asthma
让患者和护理人员参与儿科哮喘儿科临床护理中患者报告的结果测量
  • 批准号:
    495593
  • 财政年份:
    2023
  • 资助金额:
    $ 16.22万
  • 项目类别:
Air pollution and Asthma in Canada: Projections of burden and the value of climate adaptation strategies
加拿大的空气污染和哮喘:负担预测和气候适应战略的价值
  • 批准号:
    485322
  • 财政年份:
    2023
  • 资助金额:
    $ 16.22万
  • 项目类别:
    Operating Grants
Data-driven model links BMIz to gene expression in pediatric asthma
数据驱动模型将 BMIz 与小儿哮喘基因表达联系起来
  • 批准号:
    493135
  • 财政年份:
    2023
  • 资助金额:
    $ 16.22万
  • 项目类别:
BIOlogic drug safety and effectiveness interNational pharmacoepidemiologIC study in pregnant women with autoimmune disorders and asthma and their children (BIONIC)
患有自身免疫性疾病和哮喘的孕妇及其子女的生物药物安全性和有效性国际药物流行病学研究(BIONIC)
  • 批准号:
    493526
  • 财政年份:
    2023
  • 资助金额:
    $ 16.22万
  • 项目类别:
    Operating Grants
A Novel Approach to Target Neutrophilic Airway Inflammation and Airway Hyperresponsiveness in Therapy-Resistant (Refractory) Asthma.
一种针对难治性哮喘中性粒细胞性气道炎症和气道高反应性的新方法。
  • 批准号:
    10659658
  • 财政年份:
    2023
  • 资助金额:
    $ 16.22万
  • 项目类别:
Treating Maternal Depression in an Urban Community-Based Pediatric Asthma Clinic: Targeting Maternal Mood, Child Asthma Outcomes, and Health Disparities
在城市社区小儿哮喘诊所治疗孕产妇抑郁症:针对孕产妇情绪、儿童哮喘结果和健康差异
  • 批准号:
    10723233
  • 财政年份:
    2023
  • 资助金额:
    $ 16.22万
  • 项目类别:
Improving Prediction of Asthma-related Outcomes with Genetic Ancestry-informed Lung Function Equations
利用遗传祖先信息的肺功能方程改善哮喘相关结果的预测
  • 批准号:
    10723861
  • 财政年份:
    2023
  • 资助金额:
    $ 16.22万
  • 项目类别:
Prenatal Fatty Acid Supplementation and Early Childhood Asthma and Atopy in Black American Families
美国黑人家庭产前脂肪酸补充剂与儿童早期哮喘和特应性
  • 批准号:
    10586398
  • 财政年份:
    2023
  • 资助金额:
    $ 16.22万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了